Idebenone for Leber's hereditary optic neuropathy
- PMID: 27186591
- DOI: 10.1358/dot.2016.52.3.2463564
Idebenone for Leber's hereditary optic neuropathy
Abstract
Idebenone is a rapidly absorbed, safe and well-tolerated drug and is currently the only clinically proven treatment option for Leber's hereditary optic neuropathy (LHON) patients. Idebenone (Raxone®) is approved by the European Medicines Agency for the treatment of LHON and has been available on the European market since 2015. Due to its molecular mode of action of bypassing the defective mitochondrial complex I, idebenone leads to improved energy supply and a functional recovery of retinal ganglion cells during the acute stage of the disease, thereby preventing further vision loss and promoting recovery of vision. Thus, commencing treatment shortly after the onset of symptoms is likely to have the best therapeutic effect, a hypothesis that is supported by the available clinical data.
Keywords: Genetic disorders; Idebenone; Inherited mitochondrial respiratory chain diseases; LHON; Leber’s hereditary optic neuropathy; Metabolic diseases.
Copyright 2016 Prous Science, S.A.U. or its licensors. All rights reserved.
Similar articles
-
Idebenone: A Review in Leber's Hereditary Optic Neuropathy.Drugs. 2016 May;76(7):805-13. doi: 10.1007/s40265-016-0574-3. Drugs. 2016. PMID: 27071925
-
Visual function in chronic Leber's hereditary optic neuropathy during idebenone treatment initiated 5 to 50 years after onset.Graefes Arch Clin Exp Ophthalmol. 2019 Dec;257(12):2751-2757. doi: 10.1007/s00417-019-04444-6. Epub 2019 Sep 3. Graefes Arch Clin Exp Ophthalmol. 2019. PMID: 31482278
-
A randomized placebo-controlled trial of idebenone in Leber's hereditary optic neuropathy.Brain. 2011 Sep;134(Pt 9):2677-86. doi: 10.1093/brain/awr170. Epub 2011 Jul 25. Brain. 2011. PMID: 21788663 Free PMC article. Clinical Trial.
-
Idebenone in Friedreich ataxia and Leber's hereditary optic neuropathy: close mechanisms, similar therapy?Brain. 2016 Jul;139(Pt 7):e39. doi: 10.1093/brain/aww085. Epub 2016 Apr 19. Brain. 2016. PMID: 27095078 Review. No abstract available.
-
Current and Emerging Treatment Modalities for Leber's Hereditary Optic Neuropathy: A Review of the Literature.Adv Ther. 2018 Oct;35(10):1510-1518. doi: 10.1007/s12325-018-0776-z. Epub 2018 Sep 1. Adv Ther. 2018. PMID: 30173326 Free PMC article. Review.
Cited by
-
The Evaluation of Optic Nerves Using 7 Tesla "Silent" Zero Echo Time Imaging in Patients with Leber's Hereditary Optic Neuropathy with or without Idebenone Treatment.J Clin Med. 2020 Apr 13;9(4):1112. doi: 10.3390/jcm9041112. J Clin Med. 2020. PMID: 32295018 Free PMC article.
-
A Missense Mutation in OPA1 Causes Dominant Optic Atrophy in a Chinese Family.J Ophthalmol. 2019 Nov 3;2019:1424928. doi: 10.1155/2019/1424928. eCollection 2019. J Ophthalmol. 2019. PMID: 31781369 Free PMC article.
-
Atherosclerosis and Coenzyme Q10.Int J Mol Sci. 2019 Oct 20;20(20):5195. doi: 10.3390/ijms20205195. Int J Mol Sci. 2019. PMID: 31635164 Free PMC article. Review.
-
Assessment of objective visual function following idebenone administration in patients with leber hereditary optic neuropathy.Jpn J Ophthalmol. 2024 Sep;68(5):548-555. doi: 10.1007/s10384-024-01077-z. Epub 2024 Jul 5. Jpn J Ophthalmol. 2024. PMID: 38967874
-
KH176 Safeguards Mitochondrial Diseased Cells from Redox Stress-Induced Cell Death by Interacting with the Thioredoxin System/Peroxiredoxin Enzyme Machinery.Sci Rep. 2018 Apr 26;8(1):6577. doi: 10.1038/s41598-018-24900-3. Sci Rep. 2018. PMID: 29700325 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
